Skip to main content
Clinical Trials/NCT03494335
NCT03494335
Withdrawn
Not Applicable

Online Surveys to Assess the Perception and Performance of Imaging Associated Aspects

University of Cincinnati1 site in 1 countryAugust 30, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Perception of Imaging
Sponsor
University of Cincinnati
Locations
1
Primary Endpoint
Perception of PET/CT imaging agent NaF
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

In this exploratory study, the researchers would like to investigate the background, perception, current use practices, potential unmet needs and/or challenges in regard to imaging procedures, imaging technology, or any other aspect related to the broader field of imaging.

Detailed Description

The researchers plan to include volunteer participants to complete these surveys. The goal of these exploratory efforts will be to increase the currently very limited information available in the topics of interest stated above, and the findings, even if only from limited group of respondents, will help guide research development, prepare for design of clinical trials, guide special interest groups, and serve as role data for appropriate scientific publications.

Registry
clinicaltrials.gov
Start Date
August 30, 2022
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael V Knopp MD PhD

Professor

University of Cincinnati

Eligibility Criteria

Inclusion Criteria

  • Male and female participants who have access to the online survey tool and can read and write in English

Exclusion Criteria

  • None, as this is voluntary

Outcomes

Primary Outcomes

Perception of PET/CT imaging agent NaF

Time Frame: through study completion, on average 2-5 years

To evaluate participants' perceptions of NaF using a likert scale on an online survey

Perception of MRI contrast agents

Time Frame: through study completion, on average 2-5 years

To evaluate participants' perceptions of MR contrast agents using a likert scale

Perception of PET/CT imaging agent Y-90

Time Frame: through study completion, on average 2-5 years

To evaluate participants' perceptions of Y-90 using a likert scale on an online survey

Study Sites (1)

Loading locations...

Similar Trials